Why Is Baudax Bio (BXRX) Stock Up 46% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Baudax Bio (BXRX) stock is rocketing higher on Friday after the pharmaceutical company initiated a Phase 2 clinical trial of BX1000.

The post Why Is Baudax Bio (BXRX) Stock Up 46% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.